(Reuters) - The U.S. Food and Drug Administration authorized at-home sample collection for LabCorp's COVID-19 diagnostic kit, the agency said on Tuesday, allowing patients to send in their nasal swab ...

Collaboration Combines Labcorp’s Diagnostic Tests with Getlabs At-Home Phlebotomy Services Underscores Labcorp’s Commitment to Offer Consumers Choice, Convenience and Access to Health Care BURLINGTON, ...

May 12 (Reuters) - LabCorp said on Tuesday it has now made available its at-home sample collection kit for COVID-19 testing to all individuals with symptoms and possible exposure to the virus, after ...

The green light for the at-home test comes as the Trump administration and governors are scrambling to ramp up the nation's still insufficient COVID-19 testing capacity as states look to reopen ...

The first at-home mpox testing kit provides patients with convenience and privacy to test for mpox, supports physicians in detection and treatment BURLINGTON, N.C., April 10, 2024 /PRNewswire/ -- ...

LabCorp is expanding the availability of specimen testing software that should not only improve accuracy of testing but minimize the need for having tests conducted multiple times, the ...

New offering expands screening options for cervical cancer and sexually transmitted infections (STIs), including chlamydia, gonorrhea, trichomonas or mycoplasma genitalium (Mgen) BURLINGTON, N.C., ...

(Reuters) - LabCorp said on Tuesday its at-home sample collection kit for COVID-19 testing would now be available to all individuals with symptoms and possible exposure to the virus, after limiting ...